These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22972171)

  • 1. Identification of unbalanced genome copy number abnormalities in patients with multiple myeloma by single-nucleotide polymorphism genotyping microarray analysis.
    Kamada Y; Sakata-Yanagimoto M; Sanada M; Sato-Otsubo A; Enami T; Suzukawa K; Kurita N; Nishikii H; Yokoyama Y; Okoshi Y; Hasegawa Y; Ogawa S; Chiba S
    Int J Hematol; 2012 Oct; 96(4):492-500. PubMed ID: 22972171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value.
    Walker BA; Leone PE; Chiecchio L; Dickens NJ; Jenner MW; Boyd KD; Johnson DC; Gonzalez D; Dagrada GP; Protheroe RK; Konn ZJ; Stockley DM; Gregory WM; Davies FE; Ross FM; Morgan GJ
    Blood; 2010 Oct; 116(15):e56-65. PubMed ID: 20616218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect.
    Agnelli L; Mosca L; Fabris S; Lionetti M; Andronache A; Kwee I; Todoerti K; Verdelli D; Battaglia C; Bertoni F; Deliliers GL; Neri A
    Genes Chromosomes Cancer; 2009 Jul; 48(7):603-14. PubMed ID: 19396863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetics of multiple myeloma.
    Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
    Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience.
    Carballo-Zarate AA; Medeiros LJ; Fang L; Shah JJ; Weber DM; Thomas SK; Manasanch EE; Hao S; Shen Q; Orlowski RZ; Lin P; Lu X
    Mod Pathol; 2017 Jun; 30(6):843-853. PubMed ID: 28281554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
    Sawyer JR
    Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis.
    Purdie KJ; Lambert SR; Teh MT; Chaplin T; Molloy G; Raghavan M; Kelsell DP; Leigh IM; Harwood CA; Proby CM; Young BD
    Genes Chromosomes Cancer; 2007 Jul; 46(7):661-9. PubMed ID: 17420988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia.
    Okamoto R; Ogawa S; Nowak D; Kawamata N; Akagi T; Kato M; Sanada M; Weiss T; Haferlach C; Dugas M; Ruckert C; Haferlach T; Koeffler HP
    Haematologica; 2010 Sep; 95(9):1481-8. PubMed ID: 20435627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].
    Lee JW; Lee JK; Hong YJ; Hong SI; Chang YH
    Korean J Lab Med; 2008 Dec; 28(6):413-8. PubMed ID: 19127104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of single nucleotide polymorphism array in prenatal diagnosis for fetuses with abnormal ultrasound findings].
    Guo YL; Wang L; Xue SW; Qu SZ; Yang J; Xu H; Bai ZX; Liu N; Kong XD
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):464-470. PubMed ID: 30078256
    [No Abstract]   [Full Text] [Related]  

  • 11. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.
    Hagenkord JM; Monzon FA; Kash SF; Lilleberg S; Xie Q; Kant JA
    J Mol Diagn; 2010 Mar; 12(2):184-96. PubMed ID: 20075210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress of Clinical Application of SNP-A to MDS--Review].
    Chi K; Jing XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1244-1247. PubMed ID: 30111439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential analysis of chromosome aberrations in multiple myeloma during disease progression.
    Wu KL; Beverloo B; Velthuizen SJ; Sonneveld P
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):280-5. PubMed ID: 17324335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia.
    Huh J; Jung CW; Kim JW; Kim HJ; Kim SH; Shin MG; Kim YK; Kim HJ; Suh JS; Moon JH; Sohn SK; Nam GH; Lee JE; Kim DH
    Ann Hematol; 2011 Nov; 90(11):1255-64. PubMed ID: 21384125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic aberrations revealed exclusively by single nucleotide polymorphism (SNP) genotyping data in 5000 samples tested by molecular karyotyping.
    Bruno DL; White SM; Ganesamoorthy D; Burgess T; Butler K; Corrie S; Francis D; Hills L; Prabhakara K; Ngo C; Norris F; Oertel R; Pertile MD; Stark Z; Amor DJ; Slater HR
    J Med Genet; 2011 Dec; 48(12):831-9. PubMed ID: 22039585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytogenetic abnormalities in high-risk multiple myeloma].
    Ishida T
    Nihon Rinsho; 2015 Jan; 73(1):28-32. PubMed ID: 25626299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative PCR: an alternative approach to detect common copy number alterations in multiple myeloma.
    Chillón MC; Jiménez C; García-Sanz R; Alcoceba M; Prieto I; García-Alvarez M; Antón A; Maldonado R; Hernández-Ruano M; González M; Gutiérrez NC; Sarasquete ME
    Ann Hematol; 2017 Oct; 96(10):1699-1705. PubMed ID: 28770277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in Singapore.
    Lim AS; Lim TH; See KH; Ng YJ; Tan YM; Choo NS; Lim SX; Yee Y; Lau LC; Tien SL; Sathish K; Tan DC
    Chin Med J (Engl); 2013; 126(10):1872-7. PubMed ID: 23673102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience.
    Smetana J; Frohlich J; Zaoralova R; Vallova V; Greslikova H; Kupska R; Nemec P; Mikulasova A; Almasi M; Pour L; Adam Z; Sandecka V; Zahradová L; Hajek R; Kuglik P
    Biomed Res Int; 2014; 2014():209670. PubMed ID: 24987674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.